Graft-versus-host disease (GvHD): Advances at EBMT 2016
Can ibrutinib be used as a first-line treatment in CLL?
The importance of individually customized treatment for CLL patients
Trial results of idelalisib with bendamustine and rituximab in CLL
Which CLL patients would benefit from intensive therapy?